Incidence of polyneuropathy in Utrecht, the Netherlands

Neurology

Volumn 84, Issue 3, 2015, Pages 259-264

  Visser, Nora A ^a   Notermans, Nicolette C ^a   Linssen, Rosalie S N ^a   Van Den Berg, Leonard H ^a   Vrancken, Alexander F J E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CRYPTOGENIC AXONAL POLYNEUROPATHY; CYANOCOBALAMIN DEFICIENCY; DIABETIC NEUROPATHY; FEMALE; HEREDITARY POLYNEUROPATHY; HUMAN; IDIOPATHIC SMALL FIBER NEUROPATHY; IMMUNE MEDIATED POLYNEUROPATHY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC POLYNEUROPATHY; MIDDLE AGED; NETHERLANDS; POLYNEUROPATHY; PRIORITY JOURNAL; TOXIC POLYNEUROPATHY; YOUNG ADULT; ADOLESCENT; CONFIDENCE INTERVAL; ELECTRONIC MEDICAL RECORD; NEUROLOGIC EXAMINATION; POLYNEUROPATHIES; REGISTER; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; NEUROLOGIC EXAMINATION; POLYNEUROPATHIES; REGISTRIES; SEX FACTORS; YOUNG ADULT;

EID: 84925965774     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001160     Document Type: Article

References (27)

1. Baldereschi M, Inzitari M, Di Carlo A, et al. Epidemiology of distal symmetrical neuropathies in the Italian elderly. Neurology 2007;68:1460-1467.
2. Kurtzke JF. The current neurologic burden of illness and injury in the United States. Neurology 1982;32: 1207-1214.
3. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123:665-676.
4. Notermans NC, Wokke JH, van der Graaf Y, Franssen H, van Dijk GW, Jennekens FG. Chronic idiopathic axonal polyneuropathy: a five year follow up. J Neurol Neurosurg Psychiatry 1994;57:1525-1527.
5. Wolfe GI. Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system. Arch Neurol 2002;59:520-522.
6. Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol 2001;8:157-165.
7. Rudolph T, Farbu E. Hospital-referred polyneuropathies: causes, prevalences, clinical-and neurophysiological findings. Eur J Neurol 2007;14:603-608.
8. Rosenberg NR, Vermeulen M. Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy? J Neurol Neurosurg Psychiatry 2005;76: 1415-1419.
9. Statistics Netherlands. StatLine. Available at: http://statline.cbs.nl/statweb/?LA5en. Accessed May 12, 2014.
10. van Dijk GW, Notermans NC, van der Graaf Y, Donders RC, Hol M, Wokke JH. Referral of patients with polyneuropathy by the family physician: influence of type of symptoms but not of age [in Dutch]. Ned Tijdschr Geneeskd 1997;141:2342-2346.
11. Dutch Association of Neurology (NVN) and the Dutch Institute for Healthcare Improvement (CBO). Guideline polyneuropathy (Richtlijn polyneuropathie). Alphen aan den Rijn: Van Zuiden Communications B.V.; 2005. Available at: http://www.neurologie.nl/uploads/136/87/ richtlijnen-polyneuropathie.pdf.
12. van Doorn PA. Guideline on polyneuropathy [in Dutch]. Ned Tijdschr Geneeskd 2007;151:1566-1573.
13. Notermans NC, Wokke JH, Franssen H, et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993;56:1066-1071.
14. England JD, Gronseth GS, Franklin G, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidencebased review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009;72:185-192.
15. Eurostat. Available at: http://epp.eurostat.ec.europa.eu/portal/page/portal/eurostat/home/. Accessed May 13, 2014.
16. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard, 2001. Available at: http://www.who.int/en/. Accessed May 1, 2014.
17. Vrancken AF, Franssen H, Wokke JH, Teunissen LL, Notermans NC. Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people. Arch Neurol 2002;59:533-540.
18. Callaghan B, Kerber K, Longoria R, Feldman E, Lisabeth L. Capturing cases of distal symmetric polyneuropathy in a community. Muscle Nerve 2012;46: 943-947.
19. Vrancken AF, Kalmijn S, Buskens E, et al. Feasibility and cost efficiency of a diagnostic guideline for chronic polyneuropathy: a prospective implementation study. J Neurol Neurosurg Psychiatry 2006;77:397-401.
20. Jann S, Beretta S, Bramerio M, Defanti CA. Prospective follow-up study of chronic polyneuropathy of undetermined cause. Muscle Nerve 2001;24:1197-1201.
21. Gaist D, Garcia Rodriguez LA, Huerta C, Hallas J, Sindrup SH. Are users of lipid-lowering drugs at increased risk of peripheral neuropathy? Eur J Clin Pharmacol 2001; 56:931-933.
22. Lindh J, Tondel M, Osterberg A, Vrethem M. Cryptogenic polyneuropathy: clinical and neurophysiological findings. J Peripher Nerv Syst 2005;10:31-37.
23. England JD, Gronseth GS, Franklin G, et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005;64:199-207.
24. Anderson JL, Muhlestein JB, Bair TL, et al. Do statins increase the risk of idiopathic polyneuropathy? Am J Cardiol 2005;95:1097-1099.
25. Leis AA, Stokic DS, Olivier J. Statins and polyneuropathy: setting the record straight. Muscle Nerve 2005;32: 428-430.
26. Tierney EF, Thurman DJ, Beckles GL, Cadwell BL. Association of statin use with peripheral neuropathy in the U.S. population 40 years of age or older. J Diabetes 2013;5: 207-215.
27. Brass LM, Alberts MJ, Sparks L; National Lipid Association Statin Safety Task Force Neurology Expert Panel. An assessment of statin safety by neurologists. Am J Cardiol 2006;97:86C-88C.